I reckon there is going to be some company discovery during this time thanks to the ARDS COVID-19 treatment. US and other world wide investors will compare the relative risk and rewards of MSB and understand this is by no means a one hit wonder and worth the punt for all potential revenue streams and read outs coming up in the next 3-4 months.
I think investors here will be surprised when this run is sustained. Understandable negativity given the history of the company and SP, but "this time its different" - my famous last words!
I've been in and out of this stock over many years, never feeling convinced we were close enough to sustainability and a blockbuster but have bought back in last week with the comfort there are too many near term drivers of the business to ignore any longer and sentiment should be supportive given the COVID-19 opportunity and towards healthcare companies.
In better times, we normally would be doing investor presos after such interest and publicity.
- Forums
- ASX - By Stock
- MSB
- MESO action tonight
MESO action tonight, page-486
-
- There are more pages in this discussion • 2,674 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B |
Open | High | Low | Value | Volume |
$1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8683 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 32999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8683 | 1.155 |
7 | 295447 | 1.150 |
3 | 70786 | 1.145 |
6 | 196386 | 1.140 |
3 | 75486 | 1.135 |
Price($) | Vol. | No. |
---|---|---|
1.165 | 32999 | 1 |
1.170 | 62618 | 6 |
1.175 | 48590 | 3 |
1.180 | 79079 | 4 |
1.185 | 17090 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online